Lac Tran1, Michael Batech2, Connie M Rhee3, Elani Streja3, Kamyar Kalantar-Zadeh3, Steven J Jacobsen2, John J Sim1. 1. Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA. 2. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 3. Division of Nephrology and Hypertension, University of California Irvine School of Medicine, University of California Irvine Medical Center, Irvine, CA, USA.
Abstract
BACKGROUND: We hypothesized that phosphorus has an effect on anemia in both normal kidney function and early chronic kidney disease (CKD). We sought to determine whether higher phosphorus levels are associated with anemia in a large diverse population without CKD and early CKD. METHODS: This study is a historical population-based study within the Kaiser Permanente Southern California health system (1 January 1998 to 31 December 2013) among individuals aged 18 years and older with estimated glomerular filtration rate >30 mL/min/1.73 m(2) and measurements of serum phosphorus, creatinine and hemoglobin. Individuals were excluded if they had secondary causes of anemia. Odds ratio (OR) estimated for moderate anemia defined as hemoglobin <11 g/dL for both sexes. Mild anemia was defined as <12 g/dL (females) and <13 g/dL (males). RESULTS: Among 155 974 individuals, 4.1% had moderate anemia and 12.9% had mild anemia. Serum phosphorus levels ≥3.5 mg/dL were associated with both mild and moderate anemia. Moderate anemia OR (95% confidence interval) was 1.16 (1.04-1.29) for every 0.5 mg/dL phosphorus increase and 1.26 (1.07-1.48) in the highest versus middle phosphorus tertile. Additional independent anemia risk factors, including female sex, Asian race, diabetes, low albumin and low iron saturation, were observed, but did not alter the anemia-phosphorus association. CONCLUSIONS: Higher phosphorus levels were associated with a greater likelihood for anemia in a population with early CKD and normal kidney function. Phosphorus may be a biomarker for anemia and may affect aspects of hematopoiesis.
BACKGROUND: We hypothesized that phosphorus has an effect on anemia in both normal kidney function and early chronic kidney disease (CKD). We sought to determine whether higher phosphorus levels are associated with anemia in a large diverse population without CKD and early CKD. METHODS: This study is a historical population-based study within the Kaiser Permanente Southern California health system (1 January 1998 to 31 December 2013) among individuals aged 18 years and older with estimated glomerular filtration rate >30 mL/min/1.73 m(2) and measurements of serum phosphorus, creatinine and hemoglobin. Individuals were excluded if they had secondary causes of anemia. Odds ratio (OR) estimated for moderate anemia defined as hemoglobin <11 g/dL for both sexes. Mild anemia was defined as <12 g/dL (females) and <13 g/dL (males). RESULTS: Among 155 974 individuals, 4.1% had moderate anemia and 12.9% had mild anemia. Serum phosphorus levels ≥3.5 mg/dL were associated with both mild and moderate anemia. Moderate anemia OR (95% confidence interval) was 1.16 (1.04-1.29) for every 0.5 mg/dL phosphorus increase and 1.26 (1.07-1.48) in the highest versus middle phosphorus tertile. Additional independent anemia risk factors, including female sex, Asian race, diabetes, low albumin and low iron saturation, were observed, but did not alter the anemia-phosphorus association. CONCLUSIONS: Higher phosphorus levels were associated with a greater likelihood for anemia in a population with early CKD and normal kidney function. Phosphorus may be a biomarker for anemia and may affect aspects of hematopoiesis.
Authors: Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias E Larsson; Peyman Björklund Journal: Kidney Int Date: 2010-08-04 Impact factor: 10.612
Authors: Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra Journal: J Am Soc Nephrol Date: 2008-11-05 Impact factor: 10.121
Authors: Michelle M Y Wong; Charlotte Tu; Yun Li; Rachel L Perlman; Roberto Pecoits-Filho; Antonio A Lopes; Ichiei Narita; Helmut Reichel; Friedrich K Port; Nidhi Sukul; Benedicte Stengel; Bruce M Robinson; Ziad A Massy; Ronald L Pisoni Journal: Clin Kidney J Date: 2019-08-03
Authors: Brian Czaya; Kylie Heitman; Isaac Campos; Christopher Yanucil; Dominik Kentrup; David Westbrook; Orlando Gutierrez; Jodie L Babitt; Grace Jung; Isidro B Salusky; Mark Hanudel; Christian Faul Journal: Elife Date: 2022-03-18 Impact factor: 8.713
Authors: Aishatu Mohammed Nalado; Johnny N Mahlangu; Bala Waziri; Raquel Duarte; Graham Paget; Gbenga Olorunfemi; Saraladevi Naicker Journal: Int J Nephrol Renovasc Dis Date: 2019-02-18